Lexicon Pharmaceuticals, Inc.
LXRX
$2.32
-$0.02-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 190.61M | 170.66M | 96.23M | 115.95M | 139.01M |
| Total Receivables | 1.64M | 11.78M | 2.38M | 2.33M | 2.18M |
| Inventory | 1.20M | 276.00K | 281.00K | 158.00K | 168.00K |
| Prepaid Expenses | 3.13M | 3.32M | 3.00M | 4.09M | 3.73M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 196.58M | 186.03M | 101.90M | 122.53M | 145.08M |
|
|
|||||
| Total Current Assets | 196.58M | 186.03M | 101.90M | 122.53M | 145.08M |
| Net Property, Plant & Equipment | 8.57M | 8.88M | 9.18M | 9.49M | 6.59M |
| Long-term Investments | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 368.00K | 29.37M | 29.37M | 29.37M | 29.37M |
| Total Assets | 250.06M | 268.82M | 184.99M | 205.93M | 225.58M |
|
|
|||||
| Total Accounts Payable | 2.34M | 3.00M | 3.08M | 3.80M | 5.90M |
| Total Accrued Expenses | 10.72M | 5.26M | 11.55M | 11.98M | 10.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64M | 1.64M | 6.24M | 1.64M | 909.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 4.30M | 17.46M |
| Total Other Current Liabilities | -- | -- | -- | 4.30M | 17.46M |
| Total Current Liabilities | 14.71M | 9.90M | 20.87M | 21.72M | 34.84M |
|
|
|||||
| Total Current Liabilities | 14.71M | 9.90M | 20.87M | 21.72M | 34.84M |
| Long-Term Debt | 51.44M | 49.68M | 49.41M | 56.51M | 56.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.16M | 6.38M | 6.59M | 6.80M | 4.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.23M | -- | 582.00K | 740.00K | 800.00K |
| Total Liabilities | 75.54M | 65.96M | 77.45M | 85.77M | 96.14M |
|
|
|||||
| Common Stock & APIC | 2.23B | 2.22B | 2.13B | 2.13B | 2.12B |
| Retained Earnings | -2.05B | -2.02B | -2.02B | -2.00B | -1.99B |
| Treasury Stock & Other | -3.05M | -2.97M | -5.16M | -5.16M | -5.20M |
| Total Common Equity | 174.53M | 202.85M | 107.54M | 120.16M | 129.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 4.00K | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 4.00K | -- | -- | -- |
|
|
|||||
| Total Common Equity | 174.53M | 202.85M | 107.54M | 120.16M | 129.44M |
| Total Preferred Equity | -- | 4.00K | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 174.53M | 202.86M | 107.54M | 120.16M | 129.44M |
|
|
|||||